secwatch / observer
8-K filed March 30, 2026, 7:59 PM ET ticker BMNR CIK 0001829311
M&A confidence high sentiment positive materiality 0.85

Bitmine Immersion acquires Ethereum staking infrastructure firm Pier Two Holdings for up to $36.3M

BITMINE IMMERSION TECHNOLOGIES, INC.

item 1.01item 2.01item 3.02item 9.01

Machine-readable event card

schema_version
secwatch.filing_event.v1
accession
0001493152-26-013609
form_type
8-K
ticker
BMNR
cik
0001829311
company_name
BITMINE IMMERSION TECHNOLOGIES, INC.
filed_at
2026-03-30T23:59:59+00:00
discovered_at
2026-05-14T18:02:36.414632+00:00
generated_at
2026-05-15T08:26:03.933854+00:00
sec_items
["1.01", "2.01", "3.02", "9.01"]
event_type
m_and_a
sentiment
positive
materiality_score
0.85
calibrated_materiality_score
0.85
confidence
high
secwatch_canonical_url
https://secwatch.observer/filing/0001493152-26-013609
json_url
https://secwatch.observer/filing/0001493152-26-013609.json
markdown_url
https://secwatch.observer/filing/0001493152-26-013609.md
text_url
https://secwatch.observer/filing/0001493152-26-013609.txt
edgar_index_url
https://www.sec.gov/Archives/edgar/data/1829311/000149315226013609/0001493152-26-013609-index.htm
edgar_primary_document_url
https://www.sec.gov/Archives/edgar/data/1829311/000149315226013609/form8-k.htm
generated_by_model
deepseek-v4-flash:cloud@v2
review_status
machine_generated
human_reviewed
false
corrected
false
correction_note
null
correction_timestamp
null
superseded_by
null
JSON Markdown Plain text

Source-grounded claims

30e61af1cae9707ea280774740237641cf2fe45c

BITMINE IMMERSION TECHNOLOGIES, INC. completed an acquisition involving Pier Two Holdings Pty Ltd for $14,000,000 (closed 2026-03-24).

Consideration being released from such restrictions on each monthly anniversary of March 24, 2026 (the “ Closing Date ”); (iii) deferred consideration in an aggregate amount of $14,000,000, payable in a combination of cash and shares of Common Stock; and (iv) potential earnout consideration of up to $11,801,000, payable in shares of Common Stock based on the

SEC 8-K Item 2.01/5.01 confidence 0.9 SEC evidence

Comparable filings

OCFC

OceanFirst closes acquisition of Flushing Financial; issues shares to Warburg Pincus

OCEANFIRST FINANCIAL CORP June 1, 2026, 5:19 PM ET m_and_a Items 1.01, 3.02, 2.01, 2.03, 3.03, 5.02, 5.03, 7.01, 9.01

same fact type: ma_transaction same SEC item: 1.01, 2.01, 3.02, 9.01 same event type: m_and_a similar materiality

This filing

Consideration being released from such restrictions on each monthly anniversary of March 24, 2026 (the “ Closing Date ”); (iii) deferred consideration in an aggregate amount of $14,000,000, payable in a combination of cash and shares of Common Stock; and (iv) potential earnout consideration of up to $11,801,000, payable in shares of Common Stock based on the

Comparable filing

of Flushing (“ Flushing Common Stock ”) issued and outstanding immediately prior to the Effective Time, subject to certain exceptions, was converted into the right to receive 0.85 of a share (the “ Exchange Ratio ”) of common stock, par value $0.01 per share, of OceanFirst (“ OceanFirst Common Stock ” and such consideration, the “ Merger Consideration ”).

Filing page SEC filing

APAD

Enhanced Group completes de-SPAC merger with Enhanced Ltd; redemptions of $201.7M

Enhanced Group Inc. May 8, 2026, 7:59 PM ET m_and_a Items 1.01, 2.01, 5.06, 3.02, 9.01, 4.01, 3.01, 3.03, 5.01, 5.02, 5.03, 5.05, 7.01

same fact type: ma_transaction same SEC item: 1.01, 2.01, 3.02, 9.01 same event type: m_and_a similar materiality

This filing

Consideration being released from such restrictions on each monthly anniversary of March 24, 2026 (the “ Closing Date ”); (iii) deferred consideration in an aggregate amount of $14,000,000, payable in a combination of cash and shares of Common Stock; and (iv) potential earnout consideration of up to $11,801,000, payable in shares of Common Stock based on the

Comparable filing

On May 7, 2026, as contemplated by the Business Combination Agreement and as described in the section titled “ The BCA Proposal ” beginning on pa ge 180 of the Proxy Statement/Prospectus, the Company, Enhanced and Merger Sub consummated the business combination contemplated by the Business Combination Agreement, whereby: • Merger Sub merged with and into Enhanced (the “First Merger”), with Enhanced surviving the merger as a wholly owned subsidiary of the Company;

Filing page SEC filing

RMIX

Suncrete acquires Nelson Bros. Ready Mix for $42.3M cash + stock; earnout up to $18M

Suncrete, Inc. May 7, 2026, 7:59 PM ET m_and_a Items 1.01, 2.01, 3.02, 7.01, 9.01

same fact type: ma_transaction same SEC item: 1.01, 2.01, 3.02, 9.01 same event type: m_and_a similar materiality

This filing

Consideration being released from such restrictions on each monthly anniversary of March 24, 2026 (the “ Closing Date ”); (iii) deferred consideration in an aggregate amount of $14,000,000, payable in a combination of cash and shares of Common Stock; and (iv) potential earnout consideration of up to $11,801,000, payable in shares of Common Stock based on the

Comparable filing

Mr. Owens, Ms. Owens and JAO, the “Sellers”), and Jacob Owens in his capacity as representative of the Sellers. The aggregate consideration for the Acquisition consisted of (i) 1,296,456 shares of Class A Common Stock, par value $0.0001 per share, of the Company (“Class A Common Stock”) issued to the Sellers (the “Stock Consideration”) and (ii) a $42.3 million net

Filing page SEC filing

SHPH

Shuttle Pharma completes merger with United Dogecoin, pivots to crypto, raises $9.55M PIPE

Shuttle Pharmaceuticals Holdings, Inc. May 7, 2026, 7:59 PM ET m_and_a Items 1.01, 2.01, 3.02, 3.03, 5.02, 5.03, 9.01

same fact type: ma_transaction same SEC item: 1.01, 2.01, 3.02, 9.01 same event type: m_and_a similar materiality

This filing

Consideration being released from such restrictions on each monthly anniversary of March 24, 2026 (the “ Closing Date ”); (iii) deferred consideration in an aggregate amount of $14,000,000, payable in a combination of cash and shares of Common Stock; and (iv) potential earnout consideration of up to $11,801,000, payable in shares of Common Stock based on the

Comparable filing

On May 6, 2026 (the “ Closing Date ”), Shuttle Pharmaceuticals Holdings, Inc., a Delaware corporation (“ Shuttle ” or “ Acquiror ”), completed its previously announced merger pursuant to an Agreement and Plan of Merger (the “ Merger Agreement ”), entered into on April 30, 2026 by and among the Acquiror, Shuttle Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Shuttle (“ Merger Sub ”) and United Dogecoin Inc., a Delaware corporation (the “ Company ”).

Filing page SEC filing

CHRN

Ekso Bionics completes reverse merger with Applied Digital subsidiary; renames to ChronoScale Corp.

EKSO BIONICS HOLDINGS, INC. May 5, 2026, 7:59 PM ET m_and_a Items 1.01, 2.01, 2.02, 3.02, 3.03, 4.01, 5.01, 5.02, 5.03, 9.01

same fact type: ma_transaction same SEC item: 1.01, 2.01, 3.02, 9.01 same event type: m_and_a similar materiality

This filing

Consideration being released from such restrictions on each monthly anniversary of March 24, 2026 (the “ Closing Date ”); (iii) deferred consideration in an aggregate amount of $14,000,000, payable in a combination of cash and shares of Common Stock; and (iv) potential earnout consideration of up to $11,801,000, payable in shares of Common Stock based on the

Comparable filing

On May 5, 2026 (the “Closing Date”), Ekso Bionics Holdings, Inc., a Nevada corporation (“Ekso” or the “Company”), consummated the previously announced business combination transaction (the “Business Combination”) contemplated by that certain Contribution and Exchange Agreement

Filing page SEC filing

GYRE

Gyre Therapeutics completes $300M all-stock acquisition of Cullgen; appoints Ying Luo as CEO

GYRE THERAPEUTICS, INC. May 4, 2026, 7:59 PM ET m_and_a Items 2.01, 5.03, 1.01, 3.02, 3.03, 5.02, 7.01, 9.01

same fact type: ma_transaction same SEC item: 1.01, 2.01, 3.02, 9.01 same event type: m_and_a similar materiality

This filing

Consideration being released from such restrictions on each monthly anniversary of March 24, 2026 (the “ Closing Date ”); (iii) deferred consideration in an aggregate amount of $14,000,000, payable in a combination of cash and shares of Common Stock; and (iv) potential earnout consideration of up to $11,801,000, payable in shares of Common Stock based on the

Comparable filing

Revenue Code of 1986, as amended. Under the terms of the Merger Agreement, the Company acquired Cullgen in an all-stock transaction that valued Cullgen at approximately $300 million. At the effective time of the Merger (the “Effective Time”), each then outstanding share of Cullgen capital stock (the “Cullgen Capital Stock”), excluding shares of Cullgen

Filing page SEC filing

LNAI

Lunai Bioworks completes merger to acquire CNS patent portfolio; issues $20M Series B Preferred Stock

Lunai Bioworks Inc. May 1, 2026, 7:59 PM ET m_and_a Items 1.01, 2.01, 9.01, 3.01, 3.02, 3.03, 5.03

same fact type: ma_transaction same SEC item: 1.01, 2.01, 3.02, 9.01 same event type: m_and_a similar materiality

This filing

Consideration being released from such restrictions on each monthly anniversary of March 24, 2026 (the “ Closing Date ”); (iii) deferred consideration in an aggregate amount of $14,000,000, payable in a combination of cash and shares of Common Stock; and (iv) potential earnout consideration of up to $11,801,000, payable in shares of Common Stock based on the

Comparable filing

nto an Agreement and Plan of Merger (the “Merger Agreement”) with Neurobridge IP Holdings Incorporated, a Delaware corporation (“Holdings”), Lunai Bioworks IP, Inc., a Delaware corporation and a wholly owned subsidiary of the Company (“Merger

Filing page SEC filing

BKKT

Bakkt completes acquisition of DTR; issues ~11.3M shares to sellers including CEO

Bakkt, Inc. April 30, 2026, 7:59 PM ET m_and_a Items 2.01, 1.01, 3.02, 5.01, 7.01, 9.01

same fact type: ma_transaction same SEC item: 1.01, 2.01, 3.02, 9.01 same event type: m_and_a similar materiality

This filing

Consideration being released from such restrictions on each monthly anniversary of March 24, 2026 (the “ Closing Date ”); (iii) deferred consideration in an aggregate amount of $14,000,000, payable in a combination of cash and shares of Common Stock; and (iv) potential earnout consideration of up to $11,801,000, payable in shares of Common Stock based on the

Comparable filing

Purchase Agreement) for purposes of consummating the acquisition of DTR at Closing. At the closing of the acquisition of DTR (the “Closing”), the Company issued an aggregate of 11,316,775 shares (such shares, the “Consideration Shares”) of its Class A Common Stock, par value $0.0001 per share (the “Class A Common Stock”), comprised of (A) 31.5% of (i) the aggregate

Filing page SEC filing

Source: SEC EDGAR
accession 0001493152-26-013609
view filing index on sec.gov
view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.